Aytu Biopharma, Inc.
AYTU
$2.39
$0.0954.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.03% | 4.45% | 0.72% | -12.96% | 3.03% |
| Total Receivables | 19.72% | -13.60% | -22.50% | -18.38% | -12.10% |
| Inventory | -16.18% | -14.74% | -9.46% | 5.32% | -3.26% |
| Prepaid Expenses | 2.86% | -23.91% | -18.56% | -21.32% | -30.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -14.78% |
| Total Current Assets | 1.94% | -11.65% | -13.97% | -12.93% | -9.35% |
|
|
|||||
| Total Current Assets | 1.94% | -11.65% | -13.97% | -12.93% | -9.35% |
| Net Property, Plant & Equipment | -40.01% | -48.04% | -54.09% | -60.66% | -37.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -9.93% | -10.33% | -10.70% | -11.05% | -14.78% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 48.59% | 67.81% | 155.31% | -12.42% | -0.34% |
| Total Assets | -3.62% | -11.45% | -12.84% | -13.46% | -12.47% |
|
|
|||||
| Total Accounts Payable | 14.95% | 11.71% | -6.59% | -22.54% | -28.61% |
| Total Accrued Expenses | -22.52% | -15.70% | -13.27% | -10.28% | -13.93% |
| Short-term Debt | 534.28% | 291.03% | 251.44% | 53.23% | -84.80% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -87.96% | 44.82% | 3,675.81% | 91.29% | 392.22% |
| Total Finance Division Other Current Liabilities | -10.90% | -4.68% | -20.62% | -11.73% | 6.63% |
| Total Other Current Liabilities | -10.90% | -4.68% | -20.62% | -11.73% | 6.63% |
| Total Current Liabilities | -15.51% | -0.22% | -6.43% | -9.83% | -2.02% |
|
|
|||||
| Total Current Liabilities | -15.51% | -0.22% | -6.43% | -9.83% | -2.02% |
| Long-Term Debt | -- | -33.35% | -29.43% | -26.07% | -- |
| Short-term Debt | 534.28% | 291.03% | 251.44% | 53.23% | -84.80% |
| Capital Leases | 27.84% | 30.89% | 1,745.16% | -30.65% | 5,120.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -40.79% | -43.84% | -35.45% | 33.09% | 43.28% |
| Total Liabilities | -8.95% | -13.14% | -14.61% | -6.93% | -7.73% |
|
|
|||||
| Common Stock & APIC | 0.72% | 0.91% | 1.13% | 1.22% | 1.04% |
| Retained Earnings | 0.52% | -1.68% | -2.00% | -5.21% | -4.54% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 13.39% | -6.36% | -7.28% | -29.58% | -24.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.39% | -6.36% | -7.28% | -29.58% | -24.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.39% | -6.36% | -7.28% | -29.58% | -24.77% |
|
|
|||||